November 2017 Briefing – Hematology & Oncology
Here are what the editors at HealthDay consider to be the most important developments in Hematology & Oncology for November 2017. This roundup includes...
Guidelines Presented for Clinical Documentation in 21st Century
Recommendations provided for clinicians, provider institutions, government regulators, payers
Stronger Nocebo Effect When Inert Rx Labeled As Expensive
Neural interactions between cortex, brainstem, and spinal cord mediate this effect
Body Fat Linked to Breast Cancer Risk in Normal-BMI Women
High whole-body, trunk fat mass tied to higher risk of ER-positive breast cancer in postmenopausal women
Low-Cost Services a Major Player in Unnecessary Health Spending
Costs associated with low-cost, low-value health services nearly twice as high as high-cost services
Smoking + Early Menopause Increases Risk for Lung Disease, Poor Outcomes
Authors call for smoking cessation and lung cancer screening in smokers with early menopause
Professionals Disagree About Asking Patients About Sexuality
Article offers opposing views about recommendation in England to ask patients about sexual orientation
First Test to Detect Zika in Blood Donations Approved
Not designed to diagnose the infection, however
Sleep Duration, Cycle Linked to Childhood Body Weight
Shorter sleep duration, more fragmented circadian rhythms, increased intradaily variability tied to BMI
Across U.S., Wide Variation Seen in Thyroidectomy Rates
Rate per 100,000 Medicare beneficiaries ranges from 22 to 139, a 6.2-fold difference
